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Purpose: To evaluate whether using MR fluoroscopic trig-
gering technique and slow rate injection improves the
quality of arterial phase images in gadoxetic acid-DTPA-
enhanced (Gd-EOB-DTPA) MR imaging because of proper
acquisition timing and reduction of artifacts.
Materials and Methods: Two hundred sixteen patients
undergoing examination for liver diseases were retrospec-
tively reviewed. All MR images were obtained with two
Gd-EOB-DTPA injection protocols: (i) a combination pro-
tocol, in which the MR fluoroscopic triggering technique
and slow rate injection (1 mL/s) were used; and for com-
parison, (ii) a conventional protocol, in which adjusted
fixed scan delay and ordinary rate injection (2 mL/s) were
adopted. Signal-to-noise ratio (SNR) of aorta, portal vein,
and liver parenchyma on arterial phase images were cal-
culated. Two blinded readers independently evaluated the
obtained arterial phase images in terms of acquisition
timing and degree of artifacts.
Results: The SNRs of aorta and portal vein on arterial
phase images were significantly higher in the combination
protocol group (aorta/portal: 221.9 6 91.9/197.1 6 89.8)
than that in the conventional protocol group (aorta/por-
tal: 169.8 6 97.4/92.7 6 48.5) (P < 0.05). The acquisition
timing for arterial phase images with the combination
protocol was significantly better than that with the con-
ventional protocol (P < 0.01). The image quality of the
combination protocol was significantly higher than that of
the conventional protocol (P < 0.01). The occurrence rate
of moderate or severe degree of artifacts in the conven-
tional protocol (38.0%) was more prominent than that in
the combination protocol (18.5%).
Conclusion: The combination of the MR fluoroscopic trig-
gering technique and slow rate injection provides proper
arterial phase images and reduces the artifacts in Gd-
EOB-DTPA MR imaging.
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GADOXETIC ACID-DTPA (Gd-EOB-DTPA) has recently
been introduced into clinical practice as a liver-spe-
cific hepatobiliary contrast agents. Gd-EOB-DTPA is
categorized as a dual-acting agent, which simultane-
ously allows for dynamic imaging like an extracellular
agent and a liver-specific imaging agent. In addition
to the highly specific properties of Gd-EOB-DTPA for
hepatocytes, the higher T1 relaxivity of the agent in
human blood due to its weak protein binding (10%)
provides prominent enhancement in arterial phase
images, which indicates an advantage in detecting
and characterizing hypervascular tumors, such as he-
patocellular carcinoma (HCC) (1,2). Moreover, a recent
study showed that the sensitivity and specificity of
Gd-EOB-DTPA-enhanced MR imaging is superior to
that of multi-detector computed tomography (MDCT)
for the diagnosis of HCC (3). Although Gd-EOB-DTPA-
enhanced MR imaging shows the high utility with
quite small injection volume, which is 0.1 mL per 1 kg
(e.g., 5 mL for a patient with 50 kg) , this small
volume, in turn, can causes, if not properly timed, ac-
quisition timing error and peculiar artifacts, namely
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truncation artifacts (ringing artifacts, Gibbs phenom-
enon), on arterial phase images (4).
The MR fluoroscopic triggering technique is real-
time monitoring with two-dimensional (2D) fluoro-
scopic sequence after bolus administration of a con-
trast agents to detect arrival of the contrast in the ves-
sel of interest (5,6). Thus, the operator can easily
decide to start the acquisition at the appropriate arte-
rial phase timing. Although the MR fluoroscopic trig-
gering technique was originally applied to 3D MR
angiography (MRA) (5,6), it can also be applied for
abdominal dynamic imaging with 3D acquisition (e.g.,
VIBE sequence) to obtain reproducible arterial phase
images without the influence of individual distinctions.
Truncation artifacts occur because of insufficient
sampling at high spatial frequencies in k-space, and
these artifacts may alter the intensity, shape, and
anatomic detail of the structures (7,8). For proper ar-
terial phase imaging, k-space filling should match the
enhancement peak while avoiding abrupt changes in
the concentration. The latter can in fact lead to trun-
cation artifacts. In the case of small volumes of con-
trast media administered (e.g., Gd-EOB-DTPA) the
matching of the peak with proper k-space filling may
be insufficient and cause peculiar truncation artifacts
(7). This should be considered when performing
Gd-EOB-DTPA-enhanced MR imaging. To make the
matching easier, recent studies proposed the contrast
dilution method with saline to reduce truncation arti-
facts and maintain k-space homogeneity during signal
acquisition (4). On the other hand, the slow injection
rate followed by a saline chaser might have similar
effects on the contrast dilution method. The latter can
be called ‘‘intravenous dilution method,’’ but its utility
has not been intensively investigated.
The purpose of this study was to determine whether
the MR fluoroscopic triggering technique and slow rate
injection (1 mL/s) improve the quality of arterial phase
images with proper scan timing and reduction of the
artifacts on Gd-EOB-DTPA-enhanced MR imaging.
MATERIALS AND METHODS
This study endorsed the principles of the Declaration
of Helsinki and subsequent amendments (9). Our
institutional review board deemed that approval of this
study was not necessary due to the retrospective na-
ture of the evaluation. Written informed consent was
obtained from all patients. All data and information
derived from and pertaining to the study were under
the exclusive control of the investigating radiologists.
Patients
We retrospectively and randomly listed 121 eligible
patients using conventional injection protocol from
April 2006 to December 2006 and 127 eligible
patients using combination protocol from January
2007 to March 2008 on dynamic Gd-EOB-enhanced
MRI for the evaluation of liver disease. Among these
patients, 32 patients (13 in conventional protocol, 19
in combination protocol) were excluded from the
study because of (a) having multiple focal liver lesions
(more than 10 lesions) (n ¼ 12) or a large liver lesion
(more than 60 mm in diameter) (n ¼ 9), (b) massive
portal vein thrombosis (n ¼ 6), and (c) inadequate ex-
amination (n ¼ 5) (extravasation or severe adverse
events to the contrast agent) and we selected the
same number of patients (n ¼ 108) examined with
conventional or combination protocols. Finally, a total
of 216 patients (124 male, 92 female; age range, 19–
83 years; mean, 57.5 years) were enrolled in this
study. Ninety-two patients had chronic liver disease
(22 chronic hepatitis and 70 liver cirrhosis). In 128
patients with malignant hepatic lesions, the histopa-
thologic diagnosis was made by surgical resection
(n ¼ 47) and fine needle biopsy (n ¼ 59). The diagno-
sis of the remaining patients were obtained with char-
acteristic image findings (n ¼ 14) and identified
increased tumor size on the follow-up examinations
(n ¼ 8). These included HCC (n ¼ 90), cholangiocellu-
lar carcinoma (n ¼ 8), metastases of colorectal cancer
(n ¼ 18), metastases of other primary tumors (n ¼
10), and lymphoma (n ¼ 2). Among a total of 69
patients with benign focal liver lesions, 37 patients
were histopathologically verified. The remaining
patients were confirmed by characteristic image find-
ings (n ¼ 19) and stability in size of tumors on follow-
up examinations (n ¼ 13). The patients had focal nod-
ular hyperplasia (n ¼ 39), hemangioma (n ¼ 20), ade-
noma (n ¼ 3), nodular regenerative hyperplasia (n ¼
3), and other (n¼4; inflammatory pseudotumor, ab-
scess, cyst, and hamartoma).
MR Examination
MR imaging was performed with a 1.5 Tesla (T) scan-
ner 18-channel system (Avanto, Siemens Medical Sys-
tems, Erlangen, Germany) with a 45 mT/m gradient
strength (peak slew rate of 200 mT/m/ms) and a 12-
element surface phased-array coil in all patients. Pre-
saturation pulses were applied above and below the
imaging volume to reduce flow artifacts from vessels.
mSENSE (SENSE factor ¼ 2) was also applied to
reduce the scanning time. A T1-weighted 3D gradient-
echo sequence with fat saturation and volumetric
interpolated breathhold examination (VIBE; Siemens)
image was acquired before and after the administra-
tion of Gd-EOB-DTPA (PrimovistVR , Bayer Schering
Pharma, Berlin, Germany). The sequence parameters
were as follows: repetition time/echo time (TR/TE) ¼
5.29/2.57 ms, slice thickness ¼ 4 mm, intersection
gap ¼ 20%, field of view ¼ 380–500 mm, effective ma-
trix size ¼ 176  256, signal averages ¼ 1, acquisition
time ¼ 16 s, k-space trajectory, centric ordering. The
0.025 mmol/kg of body weight dose of Gd-EOB-DTPA
was administrated in all patients. After precontrast
images (e.g., T2WI, dual echo T1WI, etc.), T1-weighted
VIBE images were obtained before administration of
the contrast agent and during the arterial phase, dur-
ing the portal venous phase at 70 s, during the equi-
librium phase at 180 s, and during the hepatobiliary
phase at 5 min, 10 min, 15 min, and 20 min, respec-
tively. Dynamic MR images were obtained in the
transverse plane covering the upper abdomen during
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end-expiratory breathhold. Although other precon-
trast sequences (e.g., T2WI, dual echo T1WI etc) and
other dynamic phase (portal venous phase and equi-
librium phase) and hepatobiliary phase images at 5
min, 10 min, 15 min, and 20 min were acquired in
clinical protocols, in this study, we evaluated only
pre–T1-weighted and arterial phase images with VIBE
sequence.
Gd-EOB-DTPA Injection and Arterial Phase
Acquisition Methods in the Two Protocols
We designed two Gd-EOB-DTPA injection protocols for
comparison in this study.
(a) Combination protocol (MR fluoroscopic triggering
technique and slow injection rate, n ¼ 108): Gd-EOB-
DTPA was administrated at a rate of 1 mL/s with a
mechanical power injector (MedRad Spectris Solaris
EP) through an 20-gauge catheter inserted into an
antecubital vein, followed by 20-mL saline flush at
the same injection rate. After injection of the contrast,
real-time monitoring with the MR fluoroscopic trigger-
ing technique (CARE Bolus; Siemens) in the sagittal
plane was simultaneously started and, when the oper-
ator decided that the contrast arrived around the
bifurcation of celiac artery, arterial phase imaging
was initiated after 10 s, which represents the esti-
mated duration from abdominal aorta to peripheral
intrahepatic arterial branches, from the operator deci-
sions. Timing was, therefore, always consistent and
individual. As information, the mean starting timing
of arterial phase images over 108 patients was 30.3 s
(range, 26–38 s).
(b) Conventional protocol (adjusted two kinds of
fixed scan delay and ordinary injection rate, n ¼ 108):
Gd-EOB-DTPA was administrated at a rate of 2 mL/s
in the same way as in the combination protocols. Ar-
terial phase imaging was started at two kinds of
adjusted fixed scan delay as follows; 25–28 s for
young patients (19–50 years) without cardiovascular
disorders and 30–35 s for middle age or older patients
(51–83 years) or patients with cardiovascular disor-
ders after injection of the contrast.
Imaging analysis
Quantitative Analysis
For quantitative analysis, signal intensities (SI) of
aorta, portal vein, and liver parenchyma on arterial
phase images were measured by one radiologist, who
did not attend each reading session to minimize
bias on the measurements. Regions of interest
(ROIs) were drawn as large as possible, which was
at least 1 cm in diameter, in the structure of inter-
est, avoiding vessels for measurements of liver pa-
renchyma. The means and standard deviations
(SDs) of each target were recorded. Image noise was
measured as SD of an ROI in outside the body vol-
ume along the phase-encoding direction (10). Sig-
nal-to-noise ratio (SNR) of each organ was then cal-
culated as follows: SNR ¼ SI (target structure)/
Noise (SD of background).
Qualitative Analysis
All MR images were interpreted by two experienced
abdominal radiologists with 12 and 14 years experi-
ence, respectively, who were blinded to all clinical in-
formation. The MR images were analyzed separately
by each radiologist in two different reading sessions.
The each one session was also divided into three parts
to reduce the reading overload, which might induce a
misjudgment. In case of discrepancies between the
two readers, they were discussed in additional reading
session until a consensus was reached. To assess
optimal acquisition timing for the arterial phase, pro-
visions were made in the scoring to allow for some
scans which may have been initiated too early as well
others initiated too late. A three-point scoring system
was used, with 3 corresponding to appropriate timing,
2 as moderately inaccurate, and 1 as markedly inac-
curate. Appropriate timing (a score of 3) was defined
as the hepatic arteries and portal vein being suffi-
ciently enhanced for interpretation. A score of 2 was
defined as ‘‘moderately early’’ triggering if there was
small enhancement in the hepatic arteries and portal
vein. A score of 1 was defined as ‘‘markedly early’’ if
there was no portal vein enhancement. Similarly, for
late triggering, a score of 2 was defined as ‘‘moderately
late’’ if there was slight hepatic vein enhancement,
and a score of 1 as ‘‘markedly late’’ for hepatic paren-
chymal and hepatic vein enhancement.
For the evaluation of image quality (degree of arti-
facts) on arterial phase image, we used a 4-point rat-
ing scale (0–3). The quality was assigned as excellent
if no artifacts were observed; good when mild artifacts
were shown, but it did not interfere diagnostic inter-
pretation; poor when moderate artifacts were observed
and they did interfere with the interpretation; and
nondiagnostic, when severe artifacts were observed
impairing the assessment.
Statistical Analysis
The differences in mean age and gender distinctions
of the two groups were evaluated by t-test and chi-
square test, respectively. Interobserver variability
among the two readers was assessed by the
unweighted kappa statistics. K value range of 0.81–
1.00 was indicated as excellent agreement; 0.61–0.81,
as good; 0.41–0.60, as moderate; 0.21–0.40, as fair;
and 0.00–0.20 as poor. SNR of each organ between
the two protocols was compared using an unpaired t-
test. Differences in the grading score of the timing
and the image quality on arterial phase images with
the two injection protocols were assessed using chi-
square test. A P value of <0.05 was considered to
indicate a statistically significant difference. For sta-
tistical analysis, commercially available software
(SPSS release 15.0, SPSS) was used.
RESULTS
Interobserver Agreement
Good to excellent reader agreements (0.76–0.94) were
achieved concerning assessment of timing and image
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quality (degree of artifacts) on arterial phase images
with the two protocols (Table 1).
Patient Population (Background Factor)
There were no significant differences in terms of mean
age (P ¼ 0.263, t-test) and gender distinction (P ¼
0.116, chi-square test) of the patients between the
two groups (Table 2).
Quantitative Analysis
The SNRs of each in the two protocols are shown in
Table 3. The SNRs of the aorta and portal vein in com-
bination protocol (aorta/portal vein: 221.9 6 91.9/
197.1 6 89.8) on arterial phase was significantly
higher than that in the conventional protocol (aorta/
portal vein: 169.8 6 97.4/92.7 6 48.5, P < 0.05). The
SNR of the liver was not significantly different
between the two protocols.
Assessment of Optimal Acquisition Timing
for Arterial Phase Images
The acquisition timing for the arterial phase imaging
with the combination protocol was significantly better
than that with the conventional method (P < 0.01)
(Fig. 1; Table 1). The acquisition timing for the arterial
phase image was assigned as appropriate for 91.7%
(99/108) and 31.5% (34/108) of the patients in the
combination protocol and conventional protocol,
respectively, and significant differences were observed
in the results (P < 0.01) (Table 2). Of the patients
assigned as inappropriate timing, 100% (9/9) and
93.2% (69/74) of the patients were judged as ‘‘early’’
or ‘‘too early’’ in the combination protocol and conven-
tional protocol, respectively (Fig. 2). Whereas, of these
groups, none and only 6.8% (5/74) of the patients
were judged as ‘‘too late’’ in the combined protocol
and conventional protocol, respectively (Fig. 3).
Image Quality (Degree of Artifacts)
The results of image quality of the two protocols are
shown in Figure 4. The image quality of the combina-
tion protocol was significantly better than that of the
conventional protocol (P < 0.01) (Fig. 1). The occur-
rence rate of moderate or a severe degree of artifacts
in the conventional protocol (38.0%, 41/108) was sig-
nificantly higher than that in the combination method
(18.5%, 20/108) (P < 0.01).
DISCUSSION
Our study demonstrated that combined MR fluoro-
scopic triggering technique and slow rate injection
provided proper arterial phase images with reduction
of artifacts on Gd-EOB-DTPA MR imaging. Among se-
rial phase images on dynamic Gd-EOB-DTPA MR
imaging, the quality of arterial phase images has a
tendency to become worse, influenced by several fac-
tors, in particular, acquisition timing and the arti-
facts, such as truncation artifacts are notable in these
factors.
In the past, several methods have been proposed to
determine optimal acquisition timing in liver imaging
(6,7,11). In general, a fixed scan delay method is
adopted to determine arterial phase acquisition timing
on dynamic MR imaging, but the timing error may
often occur under injection of a small amount volume
of contrast, like Gd-EOB-DTPA with the influence of
individual variation (blood circulation, a history of
cardiovascular disease, etc.). In this study, only
31.5% (34/108) of the patients with the conventional
protocol were assigned as appropriate acquisition tim-
ing for arterial phase, although we used not one but
adjusted two kinds of scan delay, thus somehow con-
sidering individual variation, and most of these
(93.2%) were categorized as ‘‘ too early.’’
Table 1
Results of Agreements Between the Two Readers
Conventional Combination





Results of the Two Injection Protocols
Injection protocols
Conventional (n ¼ 108) Combination (n ¼ 108) P value
Mean age 57.4 6 15.5 57.5 6 14.7 n.s.
Gender 68 M 40 F 56 M 52 F n.s.
Mean score (timing of arterial phase) 1.80 6 0.89 2.92 6 .028* <0.01
Appropriciate acquisition timing 31.5% (34/108) 91.7% *(99/108) <0.01
Occurrence rate of moderate or severe artifacts 38.0%% (41/108) 18.5% *(20/108) <0.01
*Significant difference between two protocols n.s. ¼ not significant.
Table 3








(n ¼ 108) P value
Aorta 169.8 6 97.4 221.9 6 91.9* <0.05
Portal vein 92.7 6 48.5 197.1 6 89.8* <0.01
Liver 81.8 6 40.1 87.3 6 37.9 n.s.
*Significant difference between two protocols.
n.s. ¼ not significant.
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Another timing technique commonly used is ‘‘test
bolus,’’ in which a small amount of (i.e., 1 mL) of con-
trast medium is injected before the full bolus to deter-
mine aortic peak enhancement (11). Although this
method is effective for CT or MRA, the acquisition tim-
ing determined by test injection may be sometimes dif-
ferent to actual scan timing because circulatory dynam-
ics are variable at any given time. Moreover, unlike
nonspecific distributed extracellular contrast agents,
test injected Gd-EOB-DTPA is rapidly taken up into
hepatocytes and may induce unfavorable increased
liver signal, leading to less lesion-liver contrast.
The MR fluoroscopic triggering technique easily
makes the operator decide appropriate acquisition
timing for the arterial phase without unnecessary pre-
injection of the contrast (5,6). This method is a rela-
tively operator-dependent technique, but the best
results can be achieved if conducted by accomplished
operators. In this study, successful results (91.7%)
were obtained for determining acquisition timing of
arterial phase with significant differences to that of
the conventional protocol.
Another key point for obtaining sufficient good qual-
ity arterial phase images is the reduction of artifacts
of several origins.
It is worth reminding that liver imaging is commonly
affected by motion-related artifacts (body motion, re-
spiratory movement, etc.). These artifacts could be
reduced by shortening the acquisition time, for exam-
ple, by using parallel imaging (SENSE etc).
As presented in this study, recent investigators
pointed out that Gibbs or truncation artifacts, which
are also called ‘‘ringing artifacts,’’ are also an impor-
tant factor in image degradation of arterial phase on
dynamic Gd-EOB-DTPA MR imaging (4). They appear
as bright or dark lines parallel to the edge of the inter-
face, experiencing abrupt intensity changes (7). They
seem to be related to abrupt concentration changes
during the k-space filling. They can be avoided match-
ing the peak concentration homogeneous part with
the time duration of the k-space filling. This is for
example what the contrast dilution method does,
decreasing the intensity change between arteries and
surrounding soft tissues and proportional long inflow
Figure 1. Images obtained by a combination protocol in a
24-year-old woman with typical focal nodular hyperplasia.
The acquisition timing for the arterial phase image was
appropriate, and an intense enhanced mass (arrow) in the
lateral segment of the liver is clearly demonstrated. Excellent
quality images without any artifacts were obtained. A score
of 3 was assigned by both readers.
Figure 2. Images obtained by a conventional protocol in a
71-year-old man with hepatocellular carcinoma (HCC) and
liver cirrhosis (HCV and alcohol). A large HCC tumor with a
thin capsule (arrow) in the right anterior segment of the liver
was faintly enhanced due to the inappropriate ‘‘too early’’
acquisition timing. The image quality was excellent without
any artifacts.
Figure 3. Images obtained by a conventional protocol in a
56-year-old man with hepatocellular carcinoma after partial
resection and liver cirrhosis (HCV). In this patient, the acqui-
sition timing for the arterial phase was ‘‘too late’’ and both
hepatic vein (arrowheads) and liver parenchyma were already
enhanced. Mild artifacts (truncation and motion-related arti-
facts) were also observed. Note the hypointense round area
(arrow) was corresponding to the change after radiofrequency
ablation.
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of the contrast (half or one-third of total acquisition
time), thus leading to k-space homogeneity, which
results in reducing the artifacts (4). The slow rate
injection (1 mL/s) followed by a sufficient volume of
saline chaser may work the same way. Using the slow
injection method, the contrast may be naturally
diluted in intravascular space, as using the contrast
dilution method, and thus lead to reduction of ringing
artifacts as observed in this study. Another advantage
of slow injection over dilution is that the diluted con-
trast with decreased the viscosity could be passed
effectively through a venous dead space to heart and
might accelerate a sufficient protein binding process
of Gd-EOB-DTPA during the relative longer injection
time, which are contributing to higher arterial
enhancement (12–14). Because velocity of injection is
supposed to affect the peak enhancement, a higher
degree of abdominal aortic peak enhancement may be
obtained by means of a fast injection rate protocol
(e.g., 3 mL/s) (15,16). However, this mechanism may
mainly apply to the enhancement on CT or MR images
using conventional iodinated or Gadolinium-chelate
agents (17). In this study, significant higher arterial
enhancement was obtained with the combination pro-
tocol (1 mL/s) compared with the conventional proto-
col (2 mL/s). A recent study on pigs has shown that
lowering the injection rate not only ‘‘compensated for
the lower injection volume by stretching the bolus
without decreasing the peak’’ but also that ‘‘an injec-
tion rate of 1 mL/s showed better results with regard
to the arterial enhancement compared with 2 mL/s’’
(14). Therefore, this recent experience also could
support our results in the human clinical study.
Moreover, the effect of reducing the artifacts with slow
rate injection is important for achieving sufficient
enhanced high quality arterial phase images. In the
present study, the enhancement of the portal vein in
the combination protocol was also significantly higher
than that in the conventional protocol, reflecting
appropriate scanning timing.
This study has two main limitations. First, this
study was retrospective in design and we did not com-
pare the images obtained with the two protocols in
the same patient, as we selected the materials from
the patients who underwent MRI as routine clinical
examination for diagnostic purposes. Although there
is some bias on this evaluation, we believe that our
results are valid because in this evaluation we used
randomly selected and adequate number of patients,
with a same number used in the two protocols. Sec-
ond, we did not compare our combination method
with the contrast agent dilution method in this
study. Dilution is, as described above, another
effective solution for improving quality of arterial
phase images with reduction of artifacts in dynamic
Gd-EOB-DTPA MR imaging. But this method may be
not only time-consuming with regard to the prepara-
tion, because examiners have to take special care to
avoid risk of contamination at any time, but may
also be off-label without well-established evidence of
safety.
In conclusion, the combination method of MR fluo-
roscopic triggering technique and slow rate injection
contributes to proper arterial phase images with
reduction of the artifacts. We believe that this method
is the best practical solution without time-consuming
preparation or risk of contamination, reducing the
artifacts and ensuring best timing and higher image
quality in the arterial phase of Gd-EOB-DTPA MR
imaging.
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